Effects of Sorbinil, Myo-Inositol, and Aminoguanidine on Diabetic Rats
Author Information
Author(s): LAWRENCE J. COPPEY, JILL S. GELLETT, ERIC P. DAVIDSON, JOYCE A. DUNLAP, MARK A. YOREK
Primary Institution: Veterans Affairs Medical Center, Diabetes Endocrinology Research Center and Department of Internal Medicine, University of Iowa
Hypothesis
The study investigates how treatments with sorbinil, myo-inositol, or aminoguanidine affect vascular function and nerve conduction in diabetic rats.
Conclusion
Sorbinil treatment significantly improved vascular reactivity and nerve conduction in diabetic rats, while myo-inositol and aminoguanidine did not show similar benefits.
Supporting Evidence
- Sorbinil treatment improved endoneurial blood flow and motor nerve conduction velocity.
- Aminoguanidine and myo-inositol did not significantly improve vascular reactivity.
- Diabetes caused a significant decrease in Na+/K+ ATPase activity in the sciatic nerve.
Takeaway
This study shows that a medicine called sorbinil helps diabetic rats' nerves work better, but other treatments didn't help as much.
Methodology
The study involved treating diabetic rats with sorbinil, myo-inositol, or aminoguanidine and measuring their effects on blood flow and nerve conduction.
Limitations
The study did not fully correct all metabolic derangements in the diabetic rats.
Participant Demographics
Male Sprague-Dawley rats, 8-9 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website